Synergistic Cationic Amphiphilic Polymer Systems for Enhanced Therapeutic Delivery

A novel, integrated system combining cationic amphiphilic polymers with AI, IoT, blockchain, and advanced materials to revolutionize personalized medicine and therapeutic compound delivery.

The original patent disclosed cationic amphiphilic polymers for codelivery of hydrophobic agents and nucleic acids. However, the patent's limitations included lack of integration with emerging technologies and limited scalability. The new inventive concept addresses these limitations by synergistically combining the patented polymers with AI-powered predictive analytics, IoT-enabled wearable devices, blockchain-based tracking, and advanced composite materials.

The inventive concept comprises a formulation of cationic amphiphilic polymers integrated with an AI-powered predictive analytics module for optimizing therapeutic compound combinations. The system also includes a method for personalized medicine using machine learning algorithms to generate patient profiles and select customized formulations. Additionally, the system features an IoT-enabled wearable device for administering the formulation and a blockchain-based platform for secure and transparent tracking of the formulations. Furthermore, the system incorporates a composite material comprising a matrix of cationic amphiphilic polymers and a reinforcement of graphene or nanocellulose for enhanced mechanical properties in implantable devices. Finally, the system includes a real-time monitoring module using IoT-enabled sensors and cloud-based analytics for feedback to the user.

The new claims introduce the integration of AI, IoT, blockchain, and advanced materials with the patented cationic amphiphilic polymers, which is novel and non-obvious compared to the original patent. The inventive step lies in the synergistic combination of these distinct technologies to create a more powerful system for therapeutic delivery.

Alternative embodiments of the inventive concept could include integration with other emerging technologies, such as quantum computing or synthetic biology. Variations could include different types of wearable devices, alternative blockchain platforms, or modified composite materials.

The inventive concept has significant commercial potential in the personalized medicine and therapeutic delivery markets, with potential applications in cancer treatment, gene therapy, and regenerative medicine. The target industries include pharmaceutical, biotechnology, and medical device companies.